The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, phase II, double-blinded study of the efficacy of oleogel-S10 (AP101) gel for the treatment of grade 2/3 radiation dermatitis in breast cancer patients.
 
Tara Maier
No Relationships to Disclose
 
Amy Xu
Consulting or Advisory Role - AstraZeneca
 
Stephen Dusza
No Relationships to Disclose
 
Simon Powell
Consulting or Advisory Role - AstraZeneca; PharmaPier US LLC; Philips Healthcare; Rain Therapeutics; Varian Medical Systems
Research Funding - AstraZeneca; Philips Healthcare; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca
 
Andrew Barsky
Consulting or Advisory Role - Atheneum; Guidepoint Global; M3 USA Corporation; Sermo
 
Michael Bernstein
Consulting or Advisory Role - Prime Therapeutics
 
John Cuaron
No Relationships to Disclose
 
Beryl McCormick
No Relationships to Disclose
 
Marsha Reyngold
Research Funding - Elekta (Inst)
 
Dhwani Parikh
No Relationships to Disclose
 
Alina Markova
Consulting or Advisory Role - AstraZeneca; Genzyme; Incyte; Treeline Biosciences
Research Funding - Amryt Pharma; Incyte; Janssen; Kintara Therapeutics; NIH U01; NIH U54; NIH/NCI
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Incyte